about
What is the optimal dose for the prophylactic treatment of chronic migraine patients?Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment.Unilateral photophobia or phonophobia in migraine compared with trigeminal autonomic cephalalgias.Seasonal periodicity in SUNCT syndrome.Challenges of neuroprotection and neurorestoration in ischemic stroke treatment.EFNS guideline on neuroimaging in acute stroke. Report of an EFNS task force.Clinical practice guidelines in intracerebral haemorrhage.Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type.Guidelines for the treatment of acute ischaemic stroke.Stylohyoid Complex (Eagle) Syndrome Starting in a 9-Year-Old Boy.Epicardial Adipose Tissue in the General Middle-aged Population and Its Association With Metabolic Syndrome.Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphoma.[Ultrasound measurement of carotid stenosis: recommendations from the Spanish Society of Neurosonology].[Triptans in clinical practice: effectiveness, tolerance and patient's satisfaction with medication (TRIPRACLI study)].Cephalalgia alopecia or nummular headache with trophic changes? A new case with prolonged follow-up.Independent association of fibrinogen with carotid intima-media thickness in asymptomatic subjects.Clinical and neuroimaging characteristics of 14 patients with prionopathy: a descriptive study.Monitoring the Effect of Immunotherapy in Autoimmune Limbic Encephalitis Using 18F-FDG PET.Cerebellitis.Delirium due to brain microembolism: diagnostic value of diffusion-weighted MRI.Guidelines for the preventive treatment of ischaemic stroke and TIA (I). Update on risk factors and life style.Activation of the brainstem but not of the hypothalamus in hemicrania continua without autonomic symptoms.Paroxysmal hemicrania after carotid aneurysm embolization.Upper gastrointestinal bleedingrelated to migraine: the importance of education for migraine care.Dietary fibre intake is inversely associated with carotid intima-media thickness: a cross-sectional assessment in the PREDIMED study.Neuroprotection in vascular dementia.[Chronic migraine: definition, epidemiology, risk factors and treatment].[Multiple paralysis of cranial nerves due to melanoma metastases in the skull base].[Predictive factors of the response to treatment with onabotulinumtoxinA in refractory migraine][Clinical experience of treatment with onabotulinumtoxin A in patients with refractory migraine]Carotid intima-media thickness is inversely associated with olive oil consumption[Headache in the emergency department]Carotid intima-media thickness changes with Mediterranean diet: A randomized trial (PREDIMED-Navarra)Transient Blurred Vision as the Only Manifestation of Basilar StenosisThe influence of obesity on the assessment of carotid intima-media thickness[Clinical relevance of periodic limb movements during sleep in obstructive sleep apnea patients][Mitochondrial diseases and stroke][Conservative treatment of paucisymptomatic cerebral venous thrombosis]Diagnostic test for acute cerebral ischemia[On the future of the young neurologist in Spain]
P50
Q27023517-792A9F05-0EA8-4295-B885-AA021257888CQ30572460-B46004FE-BDBA-4078-987B-7BE1383DE53EQ34011201-B1F975FB-618E-439F-A35E-C66D30ED8B60Q34687475-2090F4E9-BFD4-4DAA-94D5-BE1BE15635A5Q36331046-AF610F83-63D0-47BE-883F-E91B120157B1Q36658249-FCB2004B-EB15-4975-BF7B-51F88A12D28AQ37875439-7D43826E-0063-4DAC-82F1-8CB213FD57DDQ37936617-F4BB15D8-1518-49D2-87D9-F8A1A93472CFQ37966157-14D9C207-B952-48A6-89DE-9C3724E48642Q39192292-49E61A7C-B8BE-475F-9DC7-D5269C71F343Q40456951-25F3F8A1-CC90-4246-A2A9-3C1B949DA2FFQ43551846-B3C78018-9B2A-4FF8-86AF-94A5D898C4ADQ43694555-F68D03FE-6A53-4AF2-93EF-878F86365EA2Q43764460-CF048B92-9B87-4CDF-9E88-03025F6037DEQ44231628-0D5EF76E-5899-4A5F-82EA-0C8370942B03Q44586637-244DF355-F235-4535-8F2D-C897EFEBB4D4Q48122909-F4E17C28-D4D0-45B2-A48C-32DA17B73975Q48138961-D9F8486D-49D1-4D42-8143-0353FEA806FCQ48152613-FA00FCA4-79F2-4251-A239-30AF87F7BFD9Q48198937-B921E0CB-ABD2-4D95-ACD4-18667DD3F042Q48284695-28EB5064-753B-47F2-BF81-C48B58469977Q48707569-E65258E1-783E-454D-9010-993179BAA538Q48725235-E8262CE7-913D-4A79-B71F-1C76F9105AD3Q50282299-363802A0-A86E-4729-B752-57E4A82DE451Q51422404-C80F0AC0-729D-427C-9219-56E8E56C4798Q51918249-273EDE0F-8524-4222-AAC8-079AB3F585CEQ52625150-1D8264C0-C818-4953-924D-D25A6C556B0CQ53668449-16B43521-6806-4C72-BB9F-B998CC21E212Q57774297-AC33937C-2CA3-4CE6-8EC4-67BB7BC07751Q57774315-284AD3DD-E9A9-4064-92F0-AFEFC745D3B9Q57774346-EBCAF82D-3957-43A4-94E0-7B80C6412981Q57774350-5B68236A-1F26-4B8E-B5D9-28DBC16D1094Q59282884-BB58AC7E-8FE0-471C-87F1-8F3FDE859CA5Q59854935-40C04437-42F0-4207-8A4F-40238732453AQ60146018-9C363F71-A3EA-445D-8AF1-5D761FE10411Q73577898-35C9268D-D9F3-432A-A46B-88BCF9CEB805Q77538008-CDB175B2-3F52-4161-94E6-FC5630B293F8Q78679184-423FDDCD-65A8-4B01-9A6D-215E88ED04CBQ79934734-7AB8BBB9-D735-46B6-9B19-2E50A44B81FAQ80268813-852AD633-4C4D-4052-9FB8-0E2E3C0BA61C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pablo Irimia
@ast
Pablo Irimia
@en
Pablo Irimia
@es
Pablo Irimia
@nl
Pablo Irimia
@sl
type
label
Pablo Irimia
@ast
Pablo Irimia
@en
Pablo Irimia
@es
Pablo Irimia
@nl
Pablo Irimia
@sl
prefLabel
Pablo Irimia
@ast
Pablo Irimia
@en
Pablo Irimia
@es
Pablo Irimia
@nl
Pablo Irimia
@sl
P1053
I-3259-2017
P106
P21
P31
P3829
P496
0000-0002-7238-0036